Return to Vaccination News Home Page __» Right-click to "open in new window"
Subscribe to the Vaccination NewsLetter
View past & current Scandals (columns by Sandy Mintz)
Search This Site using keywords
http://ipsapp003.lwwonline.com/content/getfile/1980/108/6/abstract.htm
Children cared for by a child minder (CM) should be less exposed to upper respiratory tract infections than those in group day care (GDC) and therefore to antibiotic treatment. Thus fewer CM children should carry resistant bacteria. To test this hypothesis nasopharyngeal carriage of Streptococcus pneumoniae (SP) and Haemophilus influenzae (HI) and exposure to recent antibiotic treatment were investigated among children in both types of care settings in the Alpes Maritimes (France) between November 1999 and March 2000.
A two stage cluster sample of children attending group day care or cared for by a child minder was selected. Nasopharyngeal samples were cultured for SP and HI. Penicillin susceptibility was tested by disk diffusion and E-test and beta-lactamase production.
We sampled 235 children in the CM group and 298 in the GDC group who were ages 6 to 36 months. Age and sex distribution were similar in both groups. S. pneumoniae was isolated in 80 children in the CM group (34.0%) and in 163 (54.7%) children in GDC (P < 10-6). Proportions of non-penicillin susceptible (NPSP) were 52.5 and 55.8%, respectively (P = 0.6). H. influenzae was present in 37.2% of children in GDC vs. 23.8% in the CM group (P < 0.001). Proportions of beta-lactamase-positive HI (HIBL+) were 40.2% vs. 46.4%, respectively (P = 0.4). Antibiotic exposure during the previous 3 months occurred in 41.3% of children in GDC and in 47.4% in the CM group (P = 0.16). There was no association between antibiotic use and carriage of NPSP or HIBL+ strains.
SP and HI carriage rates were significantly lower among children in the CM group than in GDC. The proportion of NPSP and HIBL+ was similar in both groups, and comparable patterns of antibiotic use were observed. Continued efforts must concentrate on parental education and enforcement of recommendations for management of pediatric upper respiratory tract infections.
From the Infectious Diseases Department, Nice University Hospital, Nice, France.
Accepted for publication March 3, 2003.
Address for reprints: Brigitte Dunais, M.D., Service de Maladies Infectieuses, Hôpital de l'Archet 1, BP 3079, 06202 Nice cedex, France. Fax 33 4 92 03 56 27; E-mail dunais.b@chu-nice.fr.
The results of this study were presented at the 41st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. 16
Return to Vaccination News Home Page __» Right-click to "open in new window"
DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.